Greenwood, IN, United States of America

Bernard J Abbott


Average Co-Inventor Count = 2.2

ph-index = 12

Forward Citations = 298(Granted Patents)


Company Filing History:


Years Active: 1977-1985

Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Bernard J Abbott: Innovator in Cyclic Peptide Derivatives**

Introduction

Bernard J Abbott is a renowned inventor based in Greenwood, IN, with a notable contribution to the pharmaceutical field. He holds an impressive total of 19 patents, predominantly focused on A-21978C cyclic peptides and their derivatives, marking him as a significant figure in medicinal chemistry and antibiotic development.

Latest Patents

Among his latest innovations, Abbott's patents include derivatives of A-21978C cyclic peptides. These patents detail a range of compounds represented by specific chemical formulas that demonstrate unique structural characteristics. For instance, the A-21978C cyclic peptides are designed with variations in groups that influence their chemical properties and potential applications. His work emphasizes the systematic approach to synthesizing these compounds, which have shown promise as intermediates in developing new semi-synthetic antibacterial agents.

Career Highlights

Currently, Abbott is affiliated with Eli Lilly and Company, a leader in the global pharmaceutical industry. His role involves extensive research and development related to antibiotic agents, aimed at enhancing existing treatments and discovering new therapeutic pathways. Through his work, Abbott has played a critical role in advancing the understanding and utilization of cyclic peptides in medicine.

Collaborations

In his professional journey, Abbott collaborates with esteemed colleagues such as David S Fukuda and Manuel Debono. These partnerships have facilitated a cooperative environment that fosters innovation and rigorous scientific exploration, contributing significantly to the success of their joint endeavors in pharmaceutical research.

Conclusion

Bernard J Abbott stands as a pivotal inventor in the realm of cyclic peptides, with a strong portfolio that showcases his dedication to improving healthcare through innovative scientific solutions. His ongoing contributions at Eli Lilly and Company highlight his commitment to combating bacterial infections and advancing medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…